Nomura Asset Management’s Integra LifeSciences IART Stock Holding History

Nomura Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,200	Closed	-$14.9K	–	1562
2025 Q4	$14.9K	Hold	1,200	–	–	﹤0.01%	1469
2025 Q3	$17.2K	Hold	1,200	–	–	﹤0.01%	1463
2025 Q2	$14.7K	Hold	1,200	–	–	﹤0.01%	1490
2025 Q1	$26.4K	Buy	+1,200	New	+$28.2K	﹤0.01%	1326
2024 Q3	–	Sell	-250	Closed	-$7.29K	–	1505
2024 Q2	$7.29K	Hold	250	–	–	﹤0.01%	1495
2024 Q1	$8.86K	Hold	250	–	–	﹤0.01%	1498
2023 Q4	$10.9K	Hold	250	–	–	﹤0.01%	1484
2023 Q3	$9.55K	Hold	250	–	–	﹤0.01%	1500
2023 Q2	$10.3K	Hold	250	–	–	﹤0.01%	1503
2023 Q1	$14.4K	Hold	250	–	–	﹤0.01%	1464
2022 Q4	$14K	Hold	250	–	–	﹤0.01%	1406
2022 Q3	$10.6K	Hold	250	–	–	﹤0.01%	1469
2022 Q2	$13.5K	Hold	250	–	–	﹤0.01%	1457
2022 Q1	$16.1K	Buy	+250	New	+$16.5K	﹤0.01%	1477

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nomura Asset Management's IART Position: Q1 2026 in Review

Nomura Asset Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 1,200 shares — an estimated $14.9K sold.

Nomura Asset Management first reported a position in IART in Q1 2022 and held it in 14 quarters. The position peaked at $26.4K in Q1 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Nomura Asset Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Nomura Asset Management sold 1,200 Integra LifeSciences shares in Q1 2026, an estimated $14.9K.
Nomura Asset Management first reported a position in Integra LifeSciences in Q1 2022 and held it in 14 quarters.
Nomura Asset Management's Integra LifeSciences position peaked at $26.4K in Q1 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.